4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001062993-25-004815
Chief Commercial Ofc Imm Med sold 44,665 shares at an average $6.98 ($311,792)
- Chief Commercial Ofc Imm Med acquired 109,973 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
BENZENO SHARON · Chief Commercial Ofc Imm Med
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-03-04 | Grant or award : show line 1 in the form | +109,973 | 437,388 | D | ||
| 2025-03-05 | Sale : show line 2 in the form | −41,600 | $6.98 | $290,368 | 395,788 | D |
| 2025-03-05 | Sale : show line 3 in the form | −3,065 | $6.99 | $21,424 | 392,723 | D |
| Open-market sales · 44,665 sh · avg $6.98 · $311,792 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-03-04 | Grant or award : show line 4 in the form Stock Option (right to buy) | +165,027 | 165,027 | D |
Loading xslF345X05/form4.xml…